Video

Tesh Khullar Outlines Efforts Needed to Make Sure Providers Are Comfortable Prescribing Biosimilars

Tesh Khullar, senior vice president & advisor, Flatiron Health, explains what efforts are needed to make sure providers are comfortable prescribing biosimilars.

Tesh Khullar, senior vice president & advisor, Flatiron Health, explains what efforts are needed to make sure providers are comfortable prescribing biosimilars.

Transcript

What efforts are needed to providers are comfortable with prescribing biosimilars?

I think education around what biosimilars actually are and so, the physicians I talk to give me a great analogy that they’re using biosimilars right now because of the way monoclonal antibodies are made, one batch of Rituxan is different right now than a batch of Rituxan made 2 years ago. So essentially, you’re using a biosimilar right now, and as long as there’s a cost incentive to use cheaper therapies, I think the consumers are going to look at it just like they look at generics. That’s what I believe is going to happen.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Karen Vo talks about antibullying campaigns and pediatric patients with derm conditions
Hira Ghani, DO, discusses underdiagnosed skin conditions in children
Nicole Bajic, MD
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Senator Vincent Polistina (R, New Jersey)
Amir Fathi, MD, Mass General
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo